The Discovery Channel’s Innovations with Ed Begley, Jr. Television Show to feature The FlowMetric Family of Companies
The FlowMetric Family of Companies will be featured as an innovative force within the healthcare and medical industry, on the “Innovations with Ed Begley, Jr.” television program airing in North America on Monday, March 7th at 7:30AM Eastern and Pacific Time.
This program features key opinion leaders in the field of Flow Cytometry as well as two other medical industry leaders. Specifically highlighted is FlowMetric, Inc., along with its two affiliate companies, FlowMetric Europe, S.p.A., and FlowMetric Diagnostics, Inc. showcasing the innovative services and technologies that each company provide to the pharma/biotech and medical industries.
FlowMetric’s history and successes are grounded in the company’s core application of Flow Cytometry. Since 2010, FlowMetric, Inc., has become an established CRO with an expanding global presence and as well as an emerging medical diagnostic market leader. Renold Capocasale, CEO of FlowMetric, Inc., FlowMetric Europe, S.p.A. and FlowMetric Diagnostics, Inc., notes that the inclusion of FlowMetric in this program provides “continued validation and satisfaction that [FlowMetric], as a trusted niche CRO and a medical diagnostic innovator, is making a significant impact in our industry sector by establishing quality and excellence in flow cytometry.”
Innovations is an award-wining television series hosted by the actor and environmentalist, Ed Begley Jr. The program features state-of-the-art technologies across the spectrum of healthcare, business, energy and the environment, and illustrates the impact of these in today’s world.
About The FlowMetric Family of Companies
The FlowMetric Family of Companies consist of FlowMetric, Inc. and two additional affiliate companies, FlowMetric Europe, S.p.A. and FlowMetric Diagnostics, Inc. FlowMetric, Inc. and FlowMetric Europe, S.p.A., founded in 2010 and 2013 respectively, are niche contract research organizations (CROs), focused on providing polychromatic flow cytometry and cell sorting services to bio-pharma and drug discovery companies. FlowMetric Diagnostics, Inc., founded in 2013, utilizes a flow cytometry-based platform to analyze cell-mediated immune responses. The company’s proprietary assays can be readily adapted for infection screening and immune response evaluation through highly sensitive biomarker analysis. The FlowMetric family of companies are committed to providing independent, unbiased, comprehensive and precise results delivered with an uncompromising commitment to quality.
More information can be found at: http://www.flowcytometryservices.com/flowmetric-family-of-companies.